Genetics of Pheochromocytomas and Paragangliomas
- 9 March 2017
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 46 (2) , 459-489
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- MERTK receptor tyrosine kinase is a therapeutic target in melanomaJournal of Clinical Investigation, 2013
- MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and ParagangliomaClinical Cancer Research, 2012
- Constitutive Notch pathway activation in murine ZMYM2-FGFR1–induced T-cell lymphomas associated with atypical myeloproliferative diseaseBlood, 2011
- Drug-sensitiveFGFR2mutations in endometrial carcinomaProceedings of the National Academy of Sciences, 2008
- Immunobiology of the TAM receptorsNature Reviews Immunology, 2008
- The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressorGenes & Development, 2008
- A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregationBlood, 2006
- The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteBritish Journal of Cancer, 2004
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985